To characterize the properties of T cell–derived exosomes from SLE patients, T cell–derived CD9+ and CD63+ exosomes isolated from SLE patients and healthy controls were analyzed by mass spectrometry–based proteomics. This evidence concerns the gene CD63 and systemic lupus erythematosus.